Our Products

Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More

Research & Growth

We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More

News

AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of...

AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs

WALTHAM, Mass., May 16, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Helen Milton, Ph.D., to the role More

Working at AMAG

“I have the opportunity to work on a number of different projects, both within CBR and with external research partners, that involve our newborn stem cell products.”

Kate Brown
Principle Scientist, Research and Development